As we work to bring even more value to our audience, we’ve made important changes for those who receive Ad Age with our compliments. As of November 15, 2016 we will no longer be offering full digital access to AdAge.com. However, we will continue to send you our industry-leading print issues focused on providing you with what you need to know to succeed.

If you’d like to continue your unlimited access to AdAge.com, we invite you to become a paid subscriber. Get the news, insights and tools that help you stay on top of what’s next.

FDA opens hearings on Xenical

Published on May 15, 1997.

Roche Laboratories' Xenical, its much-anticipated prescription weight-reducing drug, underwent its first hearing before a Food & Drug Administration advisory committee May 14. The session was the first step toward full approval for marketing, which could could come as soon as this fall. Lowe & Partners/SMS, New York, won the estimated $50 million to $60 million account.